Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (120)	10/23/1999 10:50:00 PM
From: tnsaf	Read Replies (1) \| Respond to of 226

An interesting site with a Medical News Alert section: pslgroup.com. Trial Is First To Activate Entire Human Immune System Against Prostate Cancer BETHESDA, MD -- October 20, 1999 -- Johns Hopkins cancer researchers report the successful use of human gene therapy to activate the human immune system against metastatic prostate cancer. The achievement, believed to be a first, could have implications in the treatment of many kinds of cancer. The study results are published in the October 15, 1999* issue of Cancer Research.